FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients ...
The FDA approved the first generic liraglutide injection, a GLP-1 receptor agonist for type 2 diabetes, addressing shortages and enhancing patient access to affordable treatments. The approval includes warnings about thyroid C-cell tumors and other risks.
Highlighted Terms
Related News
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients ...
The FDA approved the first generic liraglutide injection, a GLP-1 receptor agonist for type 2 diabetes, addressing shortages and enhancing patient access to affordable treatments. The approval includes warnings about thyroid C-cell tumors and other risks.